
How Interventional Glaucoma is Advancing Eye Care
Apr 14, 2026 - 16:19
Radio and PodcastLive Radio & Podcasts
In this episode of The Rob & Jai Show , Michael O’Rourke, CEO of Re-Vana Therapeutics, joins Dr. Rob Rothman and Dr. Jai Parekh to explore the next-generation of sustained drug delivery in ophthalmology. With millions of...
Breaking Barriers in Sustained Drug Delivery: Michael O’Rourke on The Rob & Jai Show edition of the OIS Podcast is an episode from OIS Podcast by OIS Podcast. In this episode of The Rob & Jai Show , Michael O’Rourke, CEO of Re-Vana Therapeu...
This episode belongs to OIS Podcast.
Use the player on this page to stream the episode online.
Published Mar 14, 2025, 13:44 long, audio available.
In this episode of The Rob & Jai Show , Michael O’Rourke, CEO of Re-Vana Therapeutics, joins Dr. Rob Rothman and Dr. Jai Parekh to explore the next-generation of sustained drug delivery in ophthalmology. With millions of intravitreal injections administered annually for retinal diseases like AMD, the need for longer-lasting, more effective treatments has never been greater. O’Rourke explains how Re-Vana’s proprietary hydrogel-based technologies are setting a new standard for biodegradable, sustained-release drug implants—offering six to twelve months of therapeutic coverage without the need for surgery. The discussion covers: 🔹How Re-Vana’s EyeLief™ and OcuLief™ technologies work to deliver biologics efficiently over extended periods. 🔹Why reducing injection frequency is critical for patient compliance, physician workflow, and overall treatment success. 🔹 The company’s clinical and investment strategy, including a $70M Series B raise to advance its lead asset, a six-month biodegradable fluocinolone acetonide implant. 🔹 The role of strategic partnerships in accelerating innovation, as major pharma companies seek delivery solutions for their retinal therapeutics. 🔹 The global impact of sustained-release biologics, and how Re-Vana is positioning itself as a leader in both the U.S. and European markets. With a team of seasoned industry experts, strong investor backing, and an unwavering commitment to innovation, Re-Vana Therapeutics is redefining how we approach retinal disease treatment. Don’t miss this insightful conversation—
You can listen to Breaking Barriers in Sustained Drug Delivery: Michael O’Rourke on The Rob & Jai Show edition of the OIS Podcast online on Radio and Podcast. Open the player on this page to stream the available audio.
Breaking Barriers in Sustained Drug Delivery: Michael O’Rourke on The Rob & Jai Show edition of the OIS Podcast is an episode from OIS Podcast by OIS Podcast.
This episode is 13:44 long.
This episode was published on Mar 14, 2025.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from OIS Podcast when more episodes are available from the podcast feed.
You can listen to Breaking Barriers in Sustained Drug Delivery: Michael O’Rourke on The Rob & Jai Show edition of the OIS Podcast on this page when the episode audio is available from the podcast feed.
Breaking Barriers in Sustained Drug Delivery: Michael O’Rourke on The Rob & Jai Show edition of the OIS Podcast is from OIS Podcast by OIS Podcast.
Published Mar 14, 2025 and 13:44 long